{"meta":{"query_hash":"6b4bed8a19df","filters":{"venue":"Biotechnology Law Report"},"cohort_total":16,"direct_labels_cover":0,"predictions_cover":16,"exported":16,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/6b4bed8a19df","api":"https://metacan.xera.ac/api/v1/cohort?venue=Biotechnology+Law+Report"},"results":[{"id":"W1967718889","doi":"10.1089/blr.2004.23.556","title":"Patenting of \"Higher Life Forms\" in Canada","year":2004,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Genetically Modified Organisms Research","field":"Agricultural and Biological Sciences","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Download; European union; Political science; Library science; Law; Biology; Business; International trade","score_opus":0.02110794340125666,"score_gpt":0.21907132449178793,"score_spread":0.19796338109053127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967718889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99238986,0.000070456364,0.0000031102113,0.0052640685,0.00005887385,0.00011844868,0.0000040796726,0.000035506888,0.0020555968],"genre_scores_gemma":[0.99956113,0.000011699134,0.00021112419,0.00012918991,0.000016117527,0.000006865397,0.000007975949,8.8505897e-7,0.00005503635],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988787,0.000011421078,0.0003335264,0.00024205563,0.00021885753,0.0003154491],"domain_scores_gemma":[0.9996724,0.000024638795,0.00009170414,0.00010546452,0.000042175954,0.000063608335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015120936,0.000081114515,0.00016447522,0.000013752453,0.000046947076,0.0000057061775,0.00024845873,0.00020581158,0.000121808094],"category_scores_gemma":[0.000090531816,0.00003353567,0.000028631364,0.00033271854,0.00012497461,0.000024421068,0.00014027758,0.0001822438,0.000006021554],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008688281,0.00006402286,0.050983433,0.000008009074,0.000011585527,0.00063808693,0.000004504927,0.00002568628,0.90911293,0.033373322,0.000031924144,0.005737833],"study_design_scores_gemma":[0.00018911941,0.00010359389,0.52488434,0.000015164544,0.0000031182824,0.00011150981,0.000093569295,0.000002176485,0.4597019,0.0044212076,0.010319866,0.00015446698],"about_ca_topic_score_codex":0.88922006,"about_ca_topic_score_gemma":0.9575476,"teacher_disagreement_score":0.47390088,"about_ca_system_score_codex":0.00013011516,"about_ca_system_score_gemma":0.00020555394,"threshold_uncertainty_score":0.15874073},"labels":[],"label_agreement":null},{"id":"W2029144942","doi":"10.1089/blr.2013.9911","title":"The Pharmaceutical/Biopharmaceutical Landscape—Traversing Canada's Patent and Regulatory Regimes","year":2013,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Intellectual Property and Patents","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biopharmaceutical; Traverse; Patent law; Download; Intellectual property; Political science; Law; Biotechnology; Biology; Geography; Computer science; Cartography","score_opus":0.07683336325037865,"score_gpt":0.22689901464428647,"score_spread":0.15006565139390782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029144942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8757621,0.0017201304,0.000052245516,0.049034197,0.0014668403,0.00074487465,0.0000015167562,0.00045242312,0.0707657],"genre_scores_gemma":[0.994905,0.00008003325,0.000030589483,0.0035037247,0.00022795537,0.000020491252,0.000007463533,0.000019859113,0.0012048626],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986751,0.000012227935,0.0003123417,0.0003347767,0.00022727047,0.00043827502],"domain_scores_gemma":[0.9993294,0.000053130105,0.0001327627,0.000340058,0.0001158862,0.000028752409],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003089808,0.00017998046,0.00016716888,0.00005762329,0.00064160815,0.00017469321,0.00023847392,0.00021936762,0.00021157203],"category_scores_gemma":[0.00012579163,0.000116922805,0.00003955135,0.00017470133,0.0004918591,0.00022625206,0.00025177505,0.0003545944,0.0001240361],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002971851,0.0002180761,0.021888282,0.0003818138,0.0006894601,0.0026233008,0.000053641168,0.000012488015,0.021621997,0.5755642,0.2680411,0.10860846],"study_design_scores_gemma":[0.0003188987,0.000009095065,0.0019355385,0.000022432687,0.00006341239,0.00033622058,0.00012410256,0.0023474668,0.008278255,0.001742057,0.9845785,0.0002440428],"about_ca_topic_score_codex":0.09613371,"about_ca_topic_score_gemma":0.014772757,"teacher_disagreement_score":0.7165374,"about_ca_system_score_codex":0.000040038325,"about_ca_system_score_gemma":0.000060840182,"threshold_uncertainty_score":0.9098852},"labels":[],"label_agreement":null},{"id":"W2031108337","doi":"10.1089/blr.2012.9750","title":"Securities Fraud Class Action Lawsuits Against Life Science Companies on the Rise in the First Quarter 2012","year":2012,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Legal Education and Practice Innovations","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Class action; Quarter (Canadian coin); Action (physics); Class (philosophy); Business; Law; Securities fraud; Political science; History; State (computer science); Computer science; Supreme court","score_opus":0.06849701425227893,"score_gpt":0.36705103032902103,"score_spread":0.2985540160767421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031108337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44211373,0.0001629212,0.000010823626,0.40593046,0.0012024909,0.00029192676,0.0000019890733,0.00012504062,0.15016063],"genre_scores_gemma":[0.99300754,0.00007139708,0.00003412724,0.006238676,0.000292043,0.00006791188,0.0000021019816,0.0000050670105,0.00028111323],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99856126,0.00015002339,0.00027717502,0.00018771984,0.00043293153,0.00039090714],"domain_scores_gemma":[0.99875116,0.00036427935,0.00023820015,0.00047393335,0.00012376189,0.000048685655],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0034989885,0.000094884126,0.00009750518,0.00014938602,0.001854176,0.00019775667,0.0005240069,0.00023983972,0.000096279815],"category_scores_gemma":[0.0015282173,0.000060432267,0.000031956908,0.0012038341,0.0024009915,0.0011025984,0.000042583146,0.0006955424,0.000116114745],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000036172737,0.00013924218,0.0029757791,0.0000023764694,0.000005527715,0.0000037637567,0.009895048,0.0000010428521,0.00008026447,0.9663404,0.020242406,0.00031049456],"study_design_scores_gemma":[0.00004362398,0.000014838478,0.011788545,0.000008816489,0.000005255694,0.000018842307,0.026932098,0.0000059090985,0.00047789575,0.0010932474,0.9595258,0.00008512041],"about_ca_topic_score_codex":0.0023543665,"about_ca_topic_score_gemma":0.008402922,"teacher_disagreement_score":0.9652472,"about_ca_system_score_codex":0.00012617449,"about_ca_system_score_gemma":0.0004254739,"threshold_uncertainty_score":0.99944526},"labels":[],"label_agreement":null},{"id":"W2039505100","doi":"10.1089/blr.2011.9983","title":"Expansion of the Canadian Research Exemption for Biotechnology Research Tools","year":2011,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Intellectual Property and Patents","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Download; Library science; Experimental biology; Political science; Sociology; Law; Biology; Computer science; World Wide Web; Computational biology","score_opus":0.5336590373403922,"score_gpt":0.3447900543510486,"score_spread":0.18886898298934363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039505100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8123588,0.00013429533,0.00024637856,0.017201899,0.0012813719,0.0025660517,0.000010349494,0.00033797842,0.16586289],"genre_scores_gemma":[0.9980513,0.000015194025,0.00030669835,0.00029785847,0.00015708363,0.000119503806,0.000016628564,0.00002745997,0.0010082672],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978811,0.00004880807,0.00042832215,0.00046309395,0.00042099165,0.0007576674],"domain_scores_gemma":[0.9978052,0.00007692627,0.00016769506,0.0009904605,0.000941913,0.000017838312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036160466,0.00013399206,0.00020696962,0.0009610624,0.001199098,0.000061189756,0.0008987797,0.0010852937,0.00014975054],"category_scores_gemma":[0.0020813136,0.00009413102,0.0000921398,0.001412817,0.0016291427,0.00027987012,0.0005098306,0.0008865558,0.00018106816],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011273376,0.00008326424,0.0012833314,0.00010876333,0.00003562086,0.000088148256,0.00008291715,5.5125906e-7,0.03372835,0.9481588,0.008155821,0.008161717],"study_design_scores_gemma":[0.0002530209,0.000105868705,0.0012358024,0.00008620224,0.000016304517,0.00008372095,0.0002969992,0.00012505874,0.36041456,0.050521012,0.5866793,0.0001822003],"about_ca_topic_score_codex":0.27159578,"about_ca_topic_score_gemma":0.20666863,"teacher_disagreement_score":0.8976378,"about_ca_system_score_codex":0.00013327648,"about_ca_system_score_gemma":0.0002465521,"threshold_uncertainty_score":0.9222613},"labels":[],"label_agreement":null},{"id":"W2608488164","doi":"10.1089/blr.2016.29030.mk","title":"A Decade of Data Protection for Innovative Drugs in Canada: Issues, Limitations, and Time for a Reassessment","year":2016,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CARE Canada","funders":"","keywords":"Intellectual property; Scope (computer science); Investment (military); Data Protection Act 1998; Treaty; Promotion (chess); Business; Welfare; Investment protection; International trade; Political science; International investment; Law; Foreign direct investment","score_opus":0.06956880997068911,"score_gpt":0.34301122955305424,"score_spread":0.27344241958236515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2608488164","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32151872,0.000636686,0.05559668,0.6147886,0.00023857006,0.0062656077,0.00040585102,0.0001232897,0.00042598287],"genre_scores_gemma":[0.9854277,0.00006620789,0.013794727,0.00010233132,0.000027159896,0.00015480783,0.0001582721,0.000008932746,0.00025988757],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991556,0.000009244696,0.00034792186,0.0002567916,0.00011980414,0.00011066847],"domain_scores_gemma":[0.9991735,0.00008825651,0.0001899393,0.00031938974,0.00020325104,0.000025657577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005306055,0.00006233843,0.0001927434,0.000094433315,0.000029922314,0.0000014302091,0.000059288697,0.00030193792,0.0000020659215],"category_scores_gemma":[0.00045875006,0.000041130934,0.000010167689,0.00020842669,0.00033435167,0.000045805973,0.000053833985,0.00008971871,1.2098785e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038829856,0.00016239361,0.0011724493,0.00036641676,0.00016427257,0.000032812877,0.0000701388,8.3186805e-8,0.18462892,0.24816413,0.001954699,0.56289536],"study_design_scores_gemma":[0.0064285295,0.0013035616,0.04106424,0.0009467605,0.0001523142,0.0006396692,0.0003561838,0.001998037,0.1918958,0.042907074,0.71194303,0.00036480773],"about_ca_topic_score_codex":0.09213857,"about_ca_topic_score_gemma":0.12822756,"teacher_disagreement_score":0.7099883,"about_ca_system_score_codex":0.00016762948,"about_ca_system_score_gemma":0.0010472066,"threshold_uncertainty_score":0.91390693},"labels":[],"label_agreement":null},{"id":"W2974520714","doi":"10.1089/blr.2019.29135.rbk","title":"Disharmonization in the Regulation of Transgenic Plants in Europe","year":2019,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Genetically Modified Organisms Research","field":"Agricultural and Biological Sciences","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Conestoga College","funders":"","keywords":"Parliament; European union; Member state; Legislation; Political science; Legislature; Member states; European commission; State (computer science); Genetically modified organism; Commission; Law; Public administration; Biotechnology; Business; International trade; Biology; Politics","score_opus":0.02205585330586195,"score_gpt":0.23129972475970484,"score_spread":0.20924387145384288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2974520714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951351,0.000028254994,0.0000054592333,0.0029417062,0.00002524398,0.00027843917,0.0000035154053,0.000020846368,0.0015613972],"genre_scores_gemma":[0.9997702,0.00003270791,0.000034770674,0.000034251152,0.000008074968,0.000005818271,0.00003136542,6.734049e-7,0.000082122824],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991739,0.00006498986,0.00024691733,0.00019730197,0.00016769451,0.00014920041],"domain_scores_gemma":[0.9997381,0.00004957843,0.00005877904,0.00011207423,0.00003129711,0.000010169191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038557267,0.000054393182,0.00009932589,0.000022584858,0.000019199977,0.0000072792595,0.00025340804,0.00019079781,0.00013035732],"category_scores_gemma":[0.000057898862,0.000019928075,0.000016030826,0.00062419724,0.00008568434,0.000037329675,0.000036629528,0.00014490986,0.000026009297],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011290127,0.000053161148,0.027949264,0.000003695933,0.0000014998708,0.000018786886,0.000028868277,0.000011474276,0.9594485,0.00870374,0.0000076209303,0.0037620992],"study_design_scores_gemma":[0.00009430405,0.0000986959,0.83236295,0.000008195826,9.102764e-7,0.000051200943,0.00006215147,0.00004371798,0.1623358,0.0009951923,0.0038943747,0.000052525633],"about_ca_topic_score_codex":0.0003131347,"about_ca_topic_score_gemma":0.0012077526,"teacher_disagreement_score":0.8044137,"about_ca_system_score_codex":0.000010798181,"about_ca_system_score_gemma":0.000008504473,"threshold_uncertainty_score":0.14716075},"labels":[],"label_agreement":null},{"id":"W3172086909","doi":"10.1089/blr.2021.29236.mg","title":"The EPO Guidelines They Are a-Changin’","year":2021,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Intellectual Property and Patents","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Quest University Canada","funders":"","keywords":"European patent office; German; Convention; Law; Patent application; Political science; Medicine; Business; Library science; Computer science; History","score_opus":0.15415527396539966,"score_gpt":0.26218104747449233,"score_spread":0.10802577350909268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172086909","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24621412,0.0035861698,0.0010423558,0.3002159,0.007116028,0.0007510719,0.00000560262,0.002288771,0.43877998],"genre_scores_gemma":[0.98125464,0.00011782179,0.00016672681,0.0060975594,0.0009387704,0.000024471701,0.00002748873,0.000029763487,0.011342736],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987715,0.000008253595,0.00039378362,0.00032883065,0.00017754931,0.00032009737],"domain_scores_gemma":[0.998584,0.000029111756,0.00025812013,0.00063827744,0.00048411154,0.0000064246333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004463312,0.00015138052,0.0001694617,0.00006172603,0.000598742,0.00016108553,0.00030833,0.00029241646,0.00013398737],"category_scores_gemma":[0.0011635737,0.00009464258,0.00009433683,0.0002957933,0.00017444206,0.00017000522,0.0003673209,0.00023138386,0.0006735573],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056051595,0.00012784131,0.0037178507,0.00008808008,0.00021687764,0.0066815885,0.000025614549,0.000018565845,0.008780237,0.81367993,0.14790763,0.018699743],"study_design_scores_gemma":[0.00009681023,0.0000041777307,0.0001458292,0.000029753613,0.000023801063,0.00045767718,0.00014608378,0.00018848878,0.01050986,0.011710296,0.9765386,0.00014862654],"about_ca_topic_score_codex":0.00063036405,"about_ca_topic_score_gemma":0.0016837238,"teacher_disagreement_score":0.828631,"about_ca_system_score_codex":0.000015290458,"about_ca_system_score_gemma":0.000027565597,"threshold_uncertainty_score":0.86574405},"labels":[],"label_agreement":null},{"id":"W4214559639","doi":"10.1089/blr.2008.9935","title":"Third Circuit Accepts Preemption Arguments; More Cautions About Follow-On Biologics; Health Canada Issues Approval Guidance; FDA Takes First Steps in Expanding Drug Safety; Congress Proposes Requiring “Country of Origin” Statement; Congress Wants Direct Treatment Comparisons; Further Congressional Questions About Drug Advertising; Promised Studies Not Done; Warning over Avandia; Inspections of Foreign Facilities Will Not Be Easy; FDA Guidance on Genomics Term Definitions; European Scientists Want More Nanotechnology Regulation; Geron Stem Cell Trial on Hold; South Korea Clarifies Cloning Regulations; Decisions Needed on Antivirals in Advance of Flu Epidemic; Efforts to Control Genetic Testing; Bush Signs Genetic Information Nondiscrimination Act; Drug Companies Petition for Looser Restrictions on Literature on Off-Label Uses; Merck Said to Have Violated Publishing Ethics; Trade in Biotechnology Requires Closer Control; U.N. Alleges Chinese Dissidents Being Used as Organ Sources; Recent Approvals; Approval Delays?; NIH's Open Access Policy Still Has Publishers Roiled; Tilting at the FDA","year":2008,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Intellectual Property and Patents","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Preemption; Drug control; Federal preemption; Law; Medicine; Political science; Statute; Computer science","score_opus":0.14947012980974425,"score_gpt":0.3359656712391812,"score_spread":0.18649554142943695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214559639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827679,0.0002259023,0.000420039,0.008610766,0.0004778627,0.006506533,0.0006837379,0.00015953675,0.00014772163],"genre_scores_gemma":[0.9970701,0.0002275747,0.0005929452,0.00052228547,0.000068399655,0.0006676637,0.0006771764,0.00006546127,0.00010840088],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99393415,0.00056432054,0.0027210037,0.0011343732,0.0008770418,0.0007691094],"domain_scores_gemma":[0.9939482,0.0015747083,0.0029156178,0.0008064661,0.0006857423,0.00006927292],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.002160005,0.0007151972,0.0012440139,0.0022435065,0.0017143002,0.00056179566,0.0008753585,0.00047412,0.0000034444738],"category_scores_gemma":[0.0055697653,0.0005617856,0.00012553476,0.0017888417,0.0007796092,0.002077554,0.00031446654,0.0008743641,0.000001207106],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033177704,0.003303585,0.1397707,0.0013150729,0.0009131079,0.00015272576,0.04464813,0.7273267,0.031033017,0.012183188,0.0011631247,0.0050129336],"study_design_scores_gemma":[0.08834427,0.0073248814,0.6095469,0.042660885,0.000694181,0.00013986223,0.047467895,0.03931388,0.14848836,0.0025287133,0.008673376,0.004816811],"about_ca_topic_score_codex":0.025317015,"about_ca_topic_score_gemma":0.060387373,"teacher_disagreement_score":0.68801284,"about_ca_system_score_codex":0.0017915675,"about_ca_system_score_gemma":0.00061484985,"threshold_uncertainty_score":0.9996834},"labels":[],"label_agreement":null},{"id":"W4234058516","doi":"10.1089/blr.2010.9960","title":"In the High Court of Justice Before The Hon. Mr. Justice Arnold: <i>Intervet UK Ltd. v. Merial, the Queen's University of Belfast, and the University of Saskatchewan</i> (Case no. HC09C00779)","year":2010,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Conflict of Laws and Jurisdiction","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Queen (butterfly); Economic Justice; Law; Sociology; Biology; Political science; Botany","score_opus":0.006586631673614615,"score_gpt":0.23238556536232835,"score_spread":0.22579893368871373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234058516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9238715,0.0000548889,0.00013387139,0.06915093,0.00065491354,0.00052563817,0.000042813175,0.000037506074,0.0055278917],"genre_scores_gemma":[0.9984357,0.00020258759,0.00013486916,0.00014461137,0.00009709813,6.353436e-7,0.0000022334978,0.0000052551018,0.0009770157],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99869895,0.00029501956,0.00028473113,0.00022936809,0.00028428616,0.00020766756],"domain_scores_gemma":[0.9981003,0.00035305685,0.00057904853,0.0007074829,0.00023117391,0.00002894188],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0024772573,0.000119070886,0.00027789743,0.000045067856,0.0008897327,0.000012922559,0.000761377,0.0003941946,0.00006767972],"category_scores_gemma":[0.00025510986,0.00006808392,0.00011202242,0.00035235408,0.006376892,0.000094569354,0.0002417911,0.0005464539,0.0000020531802],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007074979,0.00035815127,0.001757058,0.00015643715,0.00031119713,0.0017030112,0.07706686,0.000010257067,0.0066370196,0.9003228,0.008818849,0.0021508595],"study_design_scores_gemma":[0.0016178691,0.00022170515,0.0028156592,0.000046459332,0.0012915243,0.0006355952,0.24265055,0.000040664952,0.0024752442,0.0030371465,0.7449728,0.00019476011],"about_ca_topic_score_codex":0.13570009,"about_ca_topic_score_gemma":0.1363426,"teacher_disagreement_score":0.89728564,"about_ca_system_score_codex":0.000025490943,"about_ca_system_score_gemma":0.00016784319,"threshold_uncertainty_score":0.99632716},"labels":[],"label_agreement":null},{"id":"W4234700261","doi":"10.1089/blr.2012.9649","title":"Canada Cancels Pfizer's Viagra Patent","year":2012,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Patent law; Download; Volume (thermodynamics); Political science; Business; Law; Intellectual property; Computer science; World Wide Web; Physics","score_opus":0.018694338335708063,"score_gpt":0.2323175447619683,"score_spread":0.21362320642626026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234700261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7513153,0.0084386105,0.00054232735,0.19926183,0.0034275956,0.00074676913,0.000017802364,0.0014662995,0.034783505],"genre_scores_gemma":[0.993192,0.00032444866,0.00070796756,0.0035676039,0.00013498162,0.000028535915,0.00002808901,0.000024761634,0.0019916156],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984073,0.000013905611,0.00040731145,0.00032853143,0.00020229908,0.00064064615],"domain_scores_gemma":[0.99877053,0.000016592572,0.0001627007,0.00081394735,0.000059231657,0.00017698182],"candidate_categories":["research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0002062503,0.00020890331,0.0003808504,0.00009243806,0.00015245887,0.0000031252303,0.00014567829,0.005460321,0.00016919042],"category_scores_gemma":[0.000074148615,0.00016702068,0.00008209332,0.00025798174,0.00045529334,0.00004784933,0.00010390537,0.0024708973,0.00005133676],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021523185,0.00090325484,0.06570999,0.00016732776,0.001167974,0.01977279,0.00006496572,0.0000029750067,0.19525704,0.5997126,0.10166899,0.015356855],"study_design_scores_gemma":[0.00034007785,0.0000687227,0.0037560617,0.000027208649,0.000093552044,0.010721248,0.000029115656,0.0000024611338,0.32128462,0.000100723024,0.66341114,0.00016509337],"about_ca_topic_score_codex":0.26216075,"about_ca_topic_score_gemma":0.09764691,"teacher_disagreement_score":0.5996119,"about_ca_system_score_codex":0.00022048,"about_ca_system_score_gemma":0.0005426115,"threshold_uncertainty_score":0.9998304},"labels":[],"label_agreement":null},{"id":"W4239469862","doi":"10.1089/blr.2011.9992","title":"A Close Look at Non-Inferiority Trials; FDA Issues Guidance on Safety for Clinical Trials; Geron Human Embryonic Stem Cell Trial Starts; National Academy of Sciences Discusses Postmarketing Trials; Bone Marrow Stem Cell Trial Authorized in Israel; Canadian Company Asked to Submit Proposal on Brain Injury Treatment to DoD","year":2011,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Clinical trial; Stem cell; Medicine; Embryonic stem cell; Internal medicine; Biology","score_opus":0.21796774631967103,"score_gpt":0.4613964784922311,"score_spread":0.24342873217256006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239469862","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9195217,0.00016253328,0.000053557007,0.060884453,0.0015618678,0.016148767,0.0004351104,0.00013911998,0.0010929132],"genre_scores_gemma":[0.99263316,0.00009078303,0.0025215247,0.0008809087,0.0012518561,0.0006868372,0.000115915,0.00006215347,0.0017568434],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98500586,0.0040498376,0.0069576935,0.0016984997,0.0013532235,0.0009348949],"domain_scores_gemma":[0.9904923,0.0047265487,0.0031750277,0.0005853667,0.0003095081,0.0007112579],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.08068304,0.0006512462,0.0044122227,0.0011321516,0.00055363897,0.000047524667,0.0004565203,0.002664047,0.00005799998],"category_scores_gemma":[0.008342667,0.00044633495,0.0010087487,0.00084001775,0.0013726212,0.00009361912,0.00016584639,0.0009808476,0.0000147336705],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8257329,0.0051346016,0.0010626701,0.00038775863,0.00053236925,0.00024201203,0.0006535259,0.0000061075693,0.095873185,0.043062177,0.0046756337,0.022637049],"study_design_scores_gemma":[0.44549954,0.07859003,0.0051019522,0.0013367234,0.001034475,0.0000815811,0.00059071416,0.00018115049,0.35184547,0.0038996185,0.110223584,0.0016151464],"about_ca_topic_score_codex":0.0055728825,"about_ca_topic_score_gemma":0.0075489637,"teacher_disagreement_score":0.38023335,"about_ca_system_score_codex":0.00155913,"about_ca_system_score_gemma":0.0030578421,"threshold_uncertainty_score":0.99979883},"labels":[],"label_agreement":null},{"id":"W4243854610","doi":"10.1089/blr.2012.9659","title":"Canada May Not Approve Generic Versions of OxyContin","year":2012,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Intellectual Property and Patents","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Download; Volume (thermodynamics); Political science; Library science; Computer science; World Wide Web; Physics","score_opus":0.08033790925893307,"score_gpt":0.20725504633265995,"score_spread":0.12691713707372687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243854610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8432799,0.00016929476,0.00019594158,0.0056226603,0.001914369,0.0003019311,0.0000071517425,0.00020834853,0.1483004],"genre_scores_gemma":[0.99586767,0.000004508579,0.00015794073,0.0018518033,0.0002697191,0.000007873755,0.000023495448,0.000015017495,0.0018019757],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990148,0.0000046400123,0.00030012027,0.00018430233,0.00016594114,0.00033017562],"domain_scores_gemma":[0.9992961,0.000014555183,0.00024449383,0.00034892518,0.00008383948,0.000012079626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002248906,0.00012474306,0.00019334421,0.0000943989,0.00012745881,0.000012229549,0.00021714815,0.00022856465,0.00023450123],"category_scores_gemma":[0.00016864148,0.00010296375,0.00005060378,0.0002751436,0.000143171,0.00021855695,0.00020302678,0.00016730954,0.00010318344],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016566901,0.0005030928,0.035881404,0.00036407838,0.00033378776,0.00063452724,0.0000540107,0.000018784604,0.106723785,0.6520916,0.1933975,0.009831719],"study_design_scores_gemma":[0.00012532546,0.000006819346,0.0010318543,0.000010934765,0.00003497559,0.000070578535,0.000050186518,0.000069768794,0.06378497,0.00007668661,0.9345864,0.0001515032],"about_ca_topic_score_codex":0.51985943,"about_ca_topic_score_gemma":0.07940412,"teacher_disagreement_score":0.7411889,"about_ca_system_score_codex":0.000037915474,"about_ca_system_score_gemma":0.000075015334,"threshold_uncertainty_score":0.9373944},"labels":[],"label_agreement":null},{"id":"W4246441873","doi":"10.1089/blr.2009.9923","title":"FDA Cannot Write Definitions on Its Own; APHIS Releases Biotechnology Quality Management System; Environmental Impact Statement Needed for Alfalfa; EU Finds Monsanto Corn Safe; High-Oleic Soybeans Okayed; Farmer Irritated with Biotechnology Opponents; Canada Drops Canola Complaint Against WTO; Cambridge to Ban Level 4 Laboratories; Restriction on Use of Antibiotics in Animal Field; Eight-Feature Corn Gets U.S., Canadian Approval","year":2009,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Genetically Modified Organisms Research","field":"Agricultural and Biological Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Aphis; Canola; Agricultural science; Biotechnology; Business; Biology; Agronomy","score_opus":0.053854485882311495,"score_gpt":0.25738178063837736,"score_spread":0.20352729475606585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246441873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9647344,0.000038318023,0.00008628117,0.025273923,0.00016691892,0.00231179,0.007127324,0.00015697676,0.0001040626],"genre_scores_gemma":[0.9956717,0.00020616461,0.0015155213,0.00077182543,0.000028452081,0.000046490273,0.001685063,0.000016520647,0.00005825159],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99547553,0.00018306328,0.001076383,0.0012773292,0.0006551784,0.0013325174],"domain_scores_gemma":[0.99804825,0.0001629057,0.0004689175,0.00066801195,0.00023223583,0.00041965884],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00037351664,0.0006229394,0.00080698036,0.0004910328,0.00054872123,0.00006401691,0.0006595194,0.0013505057,0.0000131290235],"category_scores_gemma":[0.00025551542,0.00038230675,0.00009469572,0.0016818967,0.00037847512,0.00008482609,0.00017977529,0.00085275644,0.00000717899],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018683759,0.0011360548,0.0049131066,0.00009769243,0.00039998934,0.003835285,0.00003562228,0.0003079165,0.90943146,0.06820118,0.0034544389,0.0063189],"study_design_scores_gemma":[0.0016203041,0.009029536,0.30780432,0.00025343662,0.000106219435,0.0002849184,0.0017049953,0.0002367117,0.6583735,0.000043050954,0.019275114,0.0012679292],"about_ca_topic_score_codex":0.74432296,"about_ca_topic_score_gemma":0.8546734,"teacher_disagreement_score":0.30289122,"about_ca_system_score_codex":0.0021363848,"about_ca_system_score_gemma":0.00048306523,"threshold_uncertainty_score":0.99994594},"labels":[],"label_agreement":null},{"id":"W4249687475","doi":"10.1089/blr.2007.9911","title":"PTO Agrees to Review Patents on Anti-HIV Drug; Canadian Decision May or May Not Have Profound Implications; PTO Strives to Get a Handle on <i>Markush</i> Claim; CAFC Agrees Patent Law Preempts D.C. Price-Control Measure","year":2007,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Human immunodeficiency virus (HIV); Patent law; Law; Control (management); Political science; Law and economics; Business; Economics; Medicine; Virology; Intellectual property; Management","score_opus":0.084812807088495,"score_gpt":0.31325044976366906,"score_spread":0.22843764267517405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249687475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6139976,0.004373537,0.0020615407,0.26833802,0.0017759962,0.009937884,0.0034944084,0.00050901604,0.09551201],"genre_scores_gemma":[0.96280706,0.0014171433,0.0008680296,0.03283168,0.00014991176,0.00027254404,0.00007191224,0.000075957476,0.001505767],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953243,0.00003233877,0.0018271258,0.0014471178,0.00014328015,0.0012258425],"domain_scores_gemma":[0.996487,0.00016369969,0.0006983765,0.0016170348,0.00014481625,0.00088904396],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001966374,0.0005426423,0.0011266862,0.0007055955,0.00043280076,0.00012281701,0.0008403908,0.00064974366,0.00017514313],"category_scores_gemma":[0.00049417635,0.00051410124,0.00024720017,0.0005612403,0.00020400871,0.00015851174,0.00018433656,0.00056526135,0.0013786486],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010228266,0.0010136438,0.06788173,0.0003588017,0.0006352305,0.00088523683,0.000199068,0.00019601104,0.0008390351,0.83984286,0.06077554,0.026350005],"study_design_scores_gemma":[0.0010182727,0.00032420523,0.028694618,0.0004630279,0.000041794392,0.00016123439,0.000013629006,0.000026063983,0.004718727,0.0028266958,0.96092975,0.00078195217],"about_ca_topic_score_codex":0.017565848,"about_ca_topic_score_gemma":0.09828815,"teacher_disagreement_score":0.90015423,"about_ca_system_score_codex":0.00079956936,"about_ca_system_score_gemma":0.00020653993,"threshold_uncertainty_score":0.99973106},"labels":[],"label_agreement":null},{"id":"W4251060970","doi":"10.1089/0730031041724837","title":"Schmeiser <i>v.</i> Monsanto Canada Inc.,","year":2004,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Intellectual Property and Patents","field":"Business, Management and Accounting","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Download; Statutory law; Law; Statutory interpretation; Political science; Computer science; World Wide Web","score_opus":0.04458843433448383,"score_gpt":0.19539434234246,"score_spread":0.15080590800797616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251060970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72708255,0.00021652442,0.000425247,0.01942103,0.0019750022,0.0004368324,0.0000042488728,0.0009317134,0.24950685],"genre_scores_gemma":[0.99083275,0.0000074063873,0.00015013674,0.007751908,0.00027376608,0.000014144511,0.000035043486,0.000023456674,0.00091138436],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987688,0.0000025684392,0.00031506244,0.00034304996,0.00021591103,0.0003545946],"domain_scores_gemma":[0.9992727,0.0000065371137,0.00015789269,0.0004394561,0.00011131719,0.0000121070425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015510836,0.00017522012,0.00018828297,0.0001003005,0.00027284105,0.000057872257,0.00030324332,0.00028747652,0.00018445356],"category_scores_gemma":[0.00012707336,0.00014674618,0.000040998795,0.00033915477,0.00017039517,0.0002867931,0.00021327495,0.00028753848,0.00044436762],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000119559285,0.00031492804,0.0049155448,0.00017352313,0.00019864671,0.010883831,0.000021509202,0.00034013644,0.014187625,0.8866346,0.07746219,0.004747926],"study_design_scores_gemma":[0.00030851108,0.0000096356025,0.00016281146,0.000023495779,0.000021506507,0.0002791516,0.000028844845,0.00003820217,0.016673159,0.0049871616,0.9772169,0.00025060514],"about_ca_topic_score_codex":0.7984637,"about_ca_topic_score_gemma":0.599483,"teacher_disagreement_score":0.8997547,"about_ca_system_score_codex":0.0000978292,"about_ca_system_score_gemma":0.00017709972,"threshold_uncertainty_score":0.5984136},"labels":[],"label_agreement":null},{"id":"W4252964882","doi":"10.1089/blr.2006.25.389","title":"First Product from Transgenic Animal Cleared in Europe; Mab Associated with Brain Infection Allowed Back on Market; Should U.S. Approve Follow-On Biologics?; D.C. Court of Appeals Finds Constitutional Right to Unapproved Drugs; Participating in Efforts Against Counterfeiters; Specifications Issued for Veterinary Biologics and Biotechnology Products; Electronic Communications Are Desirable for Important Drug Information; Guidance for Antiviral Drug Development; Short Stories: New Indication for Remicade; Bone Stimulant Approved in Canada","year":2006,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Intellectual Property and Patents","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Clearance; Product (mathematics); Supreme court; Medicine; Food and drug administration; Law; Political science; Pharmacology","score_opus":0.0803028059876358,"score_gpt":0.24328393472962664,"score_spread":0.16298112874199083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252964882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810459,0.00008298546,0.0048945025,0.007133791,0.00010321353,0.006278312,0.00026013862,0.00009466443,0.000106492254],"genre_scores_gemma":[0.99077153,0.000025722262,0.004404964,0.00031596646,0.000043801003,0.0018804917,0.0024913338,0.00002743876,0.00003876485],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972606,0.0000394823,0.0013192762,0.00066742126,0.00015183778,0.00056140637],"domain_scores_gemma":[0.99794525,0.00034045606,0.0008763847,0.00046821937,0.00035205708,0.000017631479],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013314508,0.0003324698,0.0005604976,0.00045334897,0.0002934066,0.00004469182,0.00032358346,0.00031115947,0.0000023891873],"category_scores_gemma":[0.0013474458,0.0002960385,0.00004660674,0.00088885723,0.00029336615,0.00030928405,0.000083532184,0.0002981845,5.415686e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055618204,0.0075832317,0.3658703,0.005908723,0.0017939927,0.000083005965,0.0031965054,0.010019384,0.33191854,0.16583589,0.0391229,0.013049329],"study_design_scores_gemma":[0.021456214,0.0033269108,0.06056757,0.0036599026,0.00032613194,0.000030699382,0.001429695,0.098184474,0.2723038,0.0058732713,0.52899396,0.003847398],"about_ca_topic_score_codex":0.01888967,"about_ca_topic_score_gemma":0.21795106,"teacher_disagreement_score":0.48987105,"about_ca_system_score_codex":0.0005660207,"about_ca_system_score_gemma":0.00061601447,"threshold_uncertainty_score":0.99994916},"labels":[],"label_agreement":null}]}